A complete response letter (CRL) from the FDA delays a product's entry to the market by an average of 14 months. Companies that receive the letters take an average of seven months just to respond to them. Imagine how much you could save if you could anticipate the FDA's concerns and address them before the agency issues the complete response letter? Now you can.
St. Jude Medical, a global medical device company, announced the Population Health Research Institute has completed a preliminary analysis of data received from ongoing prospective registries that monitor the performance of the Durata and Riata ST Optim implantable cardioverter defibrillator leads. St. Jude Medical